XML 25 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note H - Stock-based Compensation
3 Months Ended
Sep. 28, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
H
.
Stock-Based Compensation
 
Performance Stock Awards (“PSA”)
 
During the
first
quarter of fiscal
2019
and
2018,
the Company granted a target number of
37.0
and
54.9
PSAs, respectively, to various employees of the Company, including executive officers. The fiscal
2019
PSAs will vest if the Company achieves performance-based target objectives relating to average return on invested capital, average annual sales and average annual Earnings Per Share (“EPS”) (as defined in the PSA Grant Agreement), in the cumulative
three
fiscal year period ending
June 30, 2021.
These PSAs are subject to adjustment if the Company’s return on invested capital, net sales, and EPS for the period falls below or exceeds the specified target objective, and the maximum number of performance shares that can be awarded if the target objective is exceeded is
55.4.
Based upon favorable actual results to date, the Company is currently accruing compensation expense for these PSAs.
 
The fiscal
2018
PSAs will vest if the Company achieves performance-based target objectives relating to average return on invested capital, average annual sales and average annual EPS (as defined in the PSA Grant Agreement), in the cumulative
three
fiscal year period ending
June 30, 2020.
These PSAs are subject to adjustment if the Company’s return on invested capital, net sales, and EPS for the period falls below or exceeds the specified target objective, and the maximum number of performance shares that can be awarded if the target objective is exceeded is
69.2.
Based upon favorable actual results to date, the Company is currently accruing compensation expense for these PSAs.
 
There were
182.7
and
224.9
unvested PSAs outstanding at
September 28, 2018
and
September 29, 2017,
respectively. The fair value of the PSAs (on the date of grant) is expensed over the performance period for the shares that are expected to ultimately vest. Compensation expense of
$546
and
$15
was recognized for the quarters ended
September 28, 2018
and
September 29, 2017,
respectively, related to PSAs. The weighted average grant date fair value of the unvested awards at
September 28, 2018
was
$15.02.
At
September 28, 2018,
the Company had
$1,683
of unrecognized compensation expense related to the unvested shares that would vest if the specified target objective was achieved for the fiscal
2019,
2018
and
2017
awards. The total fair value of PSAs vested as of
September 28, 2018
and
September 29, 2017
was
$0
.
 
Restricted Stock Awards (“RS”)
 
The Company has unvested RS awards outstanding that will vest if certain service conditions are fulfilled. The fair value of the RS grants is recorded as compensation expense over the vesting period, which is generally
1
to
3
years. During the
first
quarter of fiscal
2019
and
2018,
the Company granted
4.0
and
65.8
service based restricted shares, respectively, to employees and non-employee directors. There were
170.4
and
309.5
unvested shares outstanding at
September 28, 2018
and
September 29, 2017,
respectively. A total of
2.8
shares of restricted stock were forfeited during the quarter ended
September 28, 2018.
There were
no
shares of restricted stock forfeited during the quarter ended
September 29, 2017.
Compensation expense of
$250
and
$463
was recognized for the quarters ended
September 28, 2018
and
September 29, 2017,
respectively. The total fair value of restricted stock grants vested as of
September 28, 2018
and
September 29, 2017
was
$1,785
and
$444,
respectively. As of
September 28, 2018,
the Company had
$927
of unrecognized compensation expense related to restricted stock which will be recognized over the next
three
years.
 
Restricted Stock
Unit
Awards (“RS
U
”)
 
Under the
2018
Long Term Incentive Plan, the Company has been authorized to issue RSUs. The RSUs entitle the employee to shares of common stock of the Company if the employee remains employed by the Company through a specified date, generally
three
years from the date of grant. During the
first
quarter of fiscal
2019,
the Company granted
38.0
RSUs to various employees of the Company, including executive officers. The fair value of the RSUs (on the date of grant) is recorded as compensation expense over the vesting period. There were
38.0
unvested RSUs outstanding at
September 28, 2018.
Compensation expense of
$54
was recognized for the quarter ended
September 28, 2018.
The weighted average grant date fair value of the unvested awards at
September 28, 2018
was
$25.77.
As of
September 28, 2018,
the Company had
$924
of unrecognized compensation expense related to restricted stock which will be recognized over the next
three
years.